IgM amyloidosis: Clinical features in therapeutic outcomes

Morie Gertz, Francis K. Buadi, Suzanne R. Hayman

Research output: Contribution to journalArticle

19 Scopus citations

Abstract

It is not widely recognized that patients with amyloidosis may be associated with an IgM monoclonal protein. We reviewed the characteristics of 22 IgM amyloidosis patients seen at Mayo Clinic from 1989 through 2010 and uniformly treated with stem cell transplantation. IgM patients are older, have a higher prevalence of neuropathy, a lower incidence of cardiac involvement (lower troponin T and NT-proBNP), and a much lower level of the involved immunoglobulin free light chain.

Original languageEnglish (US)
Pages (from-to)146-148
Number of pages3
JournalClinical Lymphoma, Myeloma and Leukemia
Volume11
Issue number1
DOIs
StatePublished - Feb 1 2011

    Fingerprint

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this